CLINICAL_TRIALS
trial_result
· 2022-07-29
Clinical Trial Update: Efficacy, Safety, Preference and Response Duration of Clobex® Spray and Taclonex® Ointment in Psoriasis [Phase 4]
Summary
Phase 4 trial update assessing efficacy, safety, preference, and response duration for Clobex Spray and Taclonex Ointment in plaque psoriasis.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Galderma R&D | Conditions: Plaque Psoriasis | Phase 4 | Status: COMPLETED